since it affects so many americans, and any prophylactic treatment would likely be administered for the rest of a patient’s life, it would be extremely profitable for big pharm.
additionally, we also know the gene mutation that is responsible for PKD…
so what are the difficulties in trying to design a treatment strategy for PKD?
is the recent boom in genomics and recombinant DNA techniques likely to lead to a breakthrough?
what about increases in access to totipotent human cells for research or therapy? would this likely lead to advances in finding a treatment?
